Gilead has penned a potential $1.5 billion synthetic lethality deal with a Chinese biotech. A cell therapy company could end ...

GV Research Platform (GVRP) today announced a strategic distribution partnership with Yurogen Biosystems, a global life ...

Zenyaku Kogyo obtains Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat autoimmune haemolytic anaemia: Tokyo Friday, February 20, 2026, 13:00 Hrs [IST] Zenyaku ...

A high proportion of Salmonella and Campylobacter isolates collected from humans and food-producing animals showed increasing resistance to ciprofloxacin.

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. | Constant exposure to diverse diseases is an occupational hazard ...

Researchers at MIT and Scripps have reported that a DNA-based virus-like particle vaccine has generated markedly higher ...

Chemical engineers used a large language model to optimize DNA codon usage in the industrial yeast Komagataella phaffii. The AI-designed sequences optimized production of five proteins, offering a ...

Creation of an end-to-end antibody engine: rapid discovery paired with physiologically relevant translational assays to confirm MoA early and de-risk IND readiness.Motherwell, Scotland, [17] February ...

Different blood groups are no longer a barrier to kidney transplants in 2026. Expert explains how desensitization therapy and advanced immunology now make mismatched donor kidneys safe and highly ...

DNA origami sounds like science fiction, but for HIV vaccine researchers it is becoming a practical design tool. By folding strands of DNA into tiny three-dimensional scaffolds, scientists can arrange ...

A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make protective antibodies against HIV.